TY - STD TI - Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1–211. ID - ref1 ER - TY - JOUR AU - Russo, A. AU - Silvestro, M. AU - Tedeschi, G. AU - Tessitore PY - 2017 DA - 2017// TI - A physiopathology of migraine: what have we learned from functional imaging? JO - Curr Neurol Neurosci Rep VL - 17 UR - https://doi.org/10.1007/s11910-017-0803-5 DO - 10.1007/s11910-017-0803-5 ID - Russo2017 ER - TY - JOUR AU - Ford, J. H. AU - Jackson, J. AU - Milligan, G. AU - Cotton, S. AU - Ahl, J. AU - Aurora, S. K. PY - 2017 DA - 2017// TI - A real-world analysis of migraine: a cross-sectional study of disease burden and treatment patterns JO - Headache. VL - 57 UR - https://doi.org/10.1111/head.13202 DO - 10.1111/head.13202 ID - Ford2017 ER - TY - JOUR AU - Silberstein, S. D. AU - Holland, S. AU - Freitag, F. AU - Dodick, D. W. AU - Argoff, C. AU - Ashman, E. PY - 2012 DA - 2012// TI - Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the quality standards Subcommittee of the American Academy of neurology and the American headache society JO - Neurology. VL - 78 UR - https://doi.org/10.1212/WNL.0b013e3182535d20 DO - 10.1212/WNL.0b013e3182535d20 ID - Silberstein2012 ER - TY - JOUR AU - Goadsby, P. J. AU - Sprenger, T. PY - 2010 DA - 2010// TI - Current practice and future directions in the prevention and acute management of migraine JO - Lancet Neurol VL - 9 UR - https://doi.org/10.1016/S1474-4422(10)70005-3 DO - 10.1016/S1474-4422(10)70005-3 ID - Goadsby2010 ER - TY - STD TI - Lipton RB, Silberstein SD (2015) Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention. Headache 55(Suppl 2):103–126. ID - ref6 ER - TY - JOUR AU - Chan, C. AU - Goadsby, P. J. PY - 2019 DA - 2019// TI - Recent advances in pharmacotherapy for episodic migraine JO - CNS Drugs. VL - 33 UR - https://doi.org/10.1007/s40263-019-00665-9 DO - 10.1007/s40263-019-00665-9 ID - Chan2019 ER - TY - JOUR AU - Dodick, D. W. PY - 2019 DA - 2019// TI - CGRP ligand and receptor monoclonal antibodies for migraine prevention: evidence review and clinical implications JO - Cephalalgia. VL - 39 UR - https://doi.org/10.1177/0333102418821662 DO - 10.1177/0333102418821662 ID - Dodick2019 ER - TY - JOUR AU - Maasumi, K. AU - Michael, R. L. AU - Rapoport, A. M. PY - 2018 DA - 2018// TI - CGRP and migraine: the role of blocking calcitonin gene-related peptide ligand and receptor in the management of migraine JO - Drugs. VL - 78 UR - https://doi.org/10.1007/s40265-018-0923-5 DO - 10.1007/s40265-018-0923-5 ID - Maasumi2018 ER - TY - JOUR AU - Haanes, K. A. AU - Edvinsson, L. PY - 2019 DA - 2019// TI - Pathophysiological mechanisms in migraine and the identification of new therapeutic targets JO - CNS Drugs VL - 33 UR - https://doi.org/10.1007/s40263-019-00630-6 DO - 10.1007/s40263-019-00630-6 ID - Haanes2019 ER - TY - JOUR AU - McCafferty, E. H. AU - Lyseng-Williamson, K. A. PY - 2019 DA - 2019// TI - Erenumab in the prophylaxis of migraine: a profile of its use JO - Drugs Ther Perspect VL - 35 UR - https://doi.org/10.1007/s40267-018-0589-9 DO - 10.1007/s40267-018-0589-9 ID - McCafferty2019 ER - TY - JOUR AU - Ong, J. J. Y. AU - Wei, D. Y. AU - Goadsby, P. J. PY - 2018 DA - 2018// TI - Recent advances in pharmacotherapy for migraine prevention: from pathophysiology to new drugs JO - Drugs. VL - 78 UR - https://doi.org/10.1007/s40265-018-0865-y DO - 10.1007/s40265-018-0865-y ID - Ong2018 ER - TY - JOUR AU - Mitsikostas, D. D. AU - Reuter, U. PY - 2017 DA - 2017// TI - Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: comparisons across randomized controlled studies JO - Curr Opin Neurol VL - 30 UR - https://doi.org/10.1097/WCO.0000000000000438 DO - 10.1097/WCO.0000000000000438 ID - Mitsikostas2017 ER - TY - JOUR AU - Raffaelli, B. AU - Reuter, U. PY - 2018 DA - 2018// TI - The biology of monoclonal antibodies: focus on calcitonin gene-related peptide for prophylactic migraine therapy JO - Neurotherapeutics. VL - 15 UR - https://doi.org/10.1007/s13311-018-0622-7 DO - 10.1007/s13311-018-0622-7 ID - Raffaelli2018 ER - TY - STD TI - European Medicines Agency (EMA). 2018. Aimovig (erenumab): summary of product characteristics. Available from: https://wwwemaeuropaeu/ Accessed November 2019 ID - ref15 ER - TY - STD TI - U.S. Food and Drug Administration (FDA) (2018) AIMOVIG™ (erenumab-aooe) injection, for subcutaneous use. Highlights of Prescribing Information. https://www.accessdata.fda.gov/. Accessed 28 November 2019 ID - ref16 ER - TY - JOUR AU - Lattanzi, S. AU - Brigo, F. AU - Trinka, E. AU - Vernieri, F. AU - Corradetti, T. AU - Dobran, M. PY - 2019 DA - 2019// TI - Erenumab for preventive treatment of migraine: a systematic review and meta-analysis of efficacy and safety JO - Drugs. VL - 79 UR - https://doi.org/10.1007/s40265-019-01069-1 DO - 10.1007/s40265-019-01069-1 ID - Lattanzi2019 ER - TY - JOUR AU - Barbanti, P. AU - Aurilia, C. AU - Egeo, G. AU - Fofi, L. PY - 2019 DA - 2019// TI - Erenumab: from scientific evidence to clinical practice-the first Italian real-life data JO - Neurol Sci VL - 40 UR - https://doi.org/10.1007/s10072-019-03839-x DO - 10.1007/s10072-019-03839-x ID - Barbanti2019 ER - TY - JOUR AU - Ornello, R. AU - Casalena, A. AU - Frattale, I. AU - Gabriele, A. AU - Affaitati, G. AU - Giamberardino, M. A. PY - 2020 DA - 2020// TI - Real-life data on the efficacy and safety of erenumab in the Abruzzo region, Central Italy JO - J Headache Pain. VL - 21 UR - https://doi.org/10.1186/s10194-020-01102-9 DO - 10.1186/s10194-020-01102-9 ID - Ornello2020 ER - TY - JOUR AU - Raffaelli, B. AU - Kalantzis, R. AU - Mecklenburg, J. AU - Overeem, L. H. AU - Neeb, L. AU - Gendolla, A. PY - 2020 DA - 2020// TI - Erenumab in chronic migraine patients who previously failed five first-line oral prophylactics and onabotulinumtoxinA: a dual center retrospective observational study JO - Front Neurol VL - 11 UR - https://doi.org/10.3389/fneur.2020.00417 DO - 10.3389/fneur.2020.00417 ID - Raffaelli2020 ER - TY - JOUR AU - Lambru, G. AU - Hill, B. AU - Murphy, M. AU - Andreou, A. P. PY - 2019 DA - 2019// TI - Erenumab for the treatment of refractory chronic migraine: a UK prospective real world experience [abstract IHC-PO-390] JO - Cephalalgia. VL - 39 ID - Lambru2019 ER - TY - JOUR AU - Jenkins, B. AU - Cheng, S. AU - Limberg, N. AU - Hutton, E. PY - 2019 DA - 2019// TI - Will refractory migraine patients in the real world respond to Erenumab? [abstract IHC-PO-405] JO - Cephalalgia. VL - 39 ID - Jenkins2019 ER - TY - JOUR AU - Steiner, T. J. AU - Martelletti, P. PY - 2007 DA - 2007// TI - Aids for management of common headache disorders in primary care JO - J Headache Pain. VL - 8 ID - Steiner2007 ER - TY - JOUR AU - Silberstein, S. AU - Tfelt-Hansen, P. AU - Dodick, D. W. AU - Limmroth, V. AU - Lipton, R. B. AU - Pascual, J. PY - 2008 DA - 2008// TI - Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults JO - Cephalalgia. VL - 28 UR - https://doi.org/10.1111/j.1468-2982.2008.01555.x DO - 10.1111/j.1468-2982.2008.01555.x ID - Silberstein2008 ER - TY - JOUR AU - Lipton, R. AU - Desai, P. AU - Sapra, S. AU - Buse, D. AU - Fanning, K. AU - Reed, M. PY - 2017 DA - 2017// TI - How much change in headache-related disability is clinically meaningful? Estimating minimally important difference (MID) or change in MIDAS using data from the AMPP Study JO - Headache VL - 57 UR - https://doi.org/10.1111/head.12997 DO - 10.1111/head.12997 ID - Lipton2017 ER - TY - JOUR AU - Stewart, W. F. AU - Lipton, R. B. AU - Dowson, A. J. AU - Sawyer, J. PY - 2001 DA - 2001// TI - Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability JO - Neurology. VL - 56 UR - https://doi.org/10.1212/WNL.56.suppl_1.S20 DO - 10.1212/WNL.56.suppl_1.S20 ID - Stewart2001 ER - TY - JOUR AU - Coeytaux, R. R. AU - Kaufman, J. S. AU - Chao, R. AU - Mann, J. D. AU - Devellis, R. F. PY - 2006 DA - 2006// TI - Four methods of estimating the minimal important difference score were compared to establish a clinically significant change in headache impact test JO - J Clin Epidemiol VL - 59 UR - https://doi.org/10.1016/j.jclinepi.2005.05.010 DO - 10.1016/j.jclinepi.2005.05.010 ID - Coeytaux2006 ER - TY - JOUR AU - Kosinski, M. AU - Bayliss, M. S. AU - Bjorner, J. B. AU - Ware, J. E. AU - Garber, W. H. AU - Batenhorst, A. PY - 2003 DA - 2003// TI - A six-item short-form survey for measuring headache impact: the HIT-6 JO - Qual Life Res VL - 12 UR - https://doi.org/10.1023/A:1026119331193 DO - 10.1023/A:1026119331193 ID - Kosinski2003 ER - TY - JOUR AU - Yang, M. AU - Rendas-Baum, R. AU - Varon, S. F. AU - Kosinski, M. PY - 2011 DA - 2011// TI - Validation of the headache impact test (HIT-6) across episodic and chronic migraine JO - Cephalalgia. VL - 31 UR - https://doi.org/10.1177/0333102410379890 DO - 10.1177/0333102410379890 ID - Yang2011 ER - TY - JOUR AU - Worboys, M. PY - 2013 DA - 2013// TI - The Hamilton Rating Scale for Depression: The making of a “gold standard” and the unmaking of a chronic illness, 1960-1980 JO - Chronic Illn VL - 9 UR - https://doi.org/10.1177/1742395312467658 DO - 10.1177/1742395312467658 ID - Worboys2013 ER - TY - JOUR AU - Maier, W. AU - Buller, R. AU - Philipp, M. AU - Heuser, I. PY - 1988 DA - 1988// TI - The Hamilton anxiety scale: reliability, validity and sensitivity to change in anxiety and depressive disorders JO - J Affect Disord VL - 14 UR - https://doi.org/10.1016/0165-0327(88)90072-9 DO - 10.1016/0165-0327(88)90072-9 ID - Maier1988 ER - TY - STD TI - Stewart A, Ware JE, Brook RH, Davies AR (1978) Conceptualization and measurement of health for adults in the health insurance study: Vol. II, physical health in terms of functioning. Rand Corporation, Santa Monica, CA, USA ID - ref32 ER - TY - JOUR AU - Cole, J. C. AU - Lin, P. AU - Rupnow, M. F. PY - 2009 DA - 2009// TI - Minimal important differences in the migraine-specific quality of life questionnaire (MSQ) version JO - Cephalalgia. VL - 29 UR - https://doi.org/10.1111/j.1468-2982.2009.01852.x DO - 10.1111/j.1468-2982.2009.01852.x ID - Cole2009 ER - TY - JOUR AU - Jhingran, P. AU - Osterhaus, J. T. AU - Miller, D. W. AU - Lee, J. T. AU - Kirchdoerfer, L. PY - 1998 DA - 1998// TI - Development and validation of the migraine-specific quality of life questionnaire JO - Headache. VL - 38 UR - https://doi.org/10.1046/j.1526-4610.1998.3804295.x DO - 10.1046/j.1526-4610.1998.3804295.x ID - Jhingran1998 ER - TY - JOUR AU - Sullivan, M. J. AU - Bishop, S. R. AU - Pivik, J. PY - 1995 DA - 1995// TI - The pain catastrophizing scale: development and validation JO - Psychol Assess VL - 7 UR - https://doi.org/10.1037/1040-3590.7.4.524 DO - 10.1037/1040-3590.7.4.524 ID - Sullivan1995 ER - TY - JOUR AU - Melhado, E. M. AU - Thiers Rister, H. L. AU - Galego, D. R. AU - Oliveira, A. B. AU - Buttarello, I. A. AU - Belucio, I. S. PY - 2020 DA - 2020// TI - Allodynia in menstrually related migraine: score assessment by Allodynia symptom checklist (ASC-12) JO - Headache. VL - 60 UR - https://doi.org/10.1111/head.13677 DO - 10.1111/head.13677 ID - Melhado2020 ER - TY - JOUR AU - Gil-Gouveia, R. AU - Oliveira, A. G. AU - Martins, I. P. PY - 2011 DA - 2011// TI - A subjective cognitive impairment scale for migraine attacks. The MIG-SCOG: development and validation JO - Cephalalgia. VL - 31 UR - https://doi.org/10.1177/0333102411408359 DO - 10.1177/0333102411408359 ID - Gil-Gouveia2011 ER - TY - JOUR AU - Elm, E. AU - Altman, D. G. AU - Egger, M. AU - Pocock, S. J. AU - Gotzsche, P. C. AU - Vandenbroucke, J. P. PY - 2007 DA - 2007// TI - The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies JO - Lancet. VL - 370 UR - https://doi.org/10.1016/S0140-6736(07)61602-X DO - 10.1016/S0140-6736(07)61602-X ID - Elm2007 ER - TY - JOUR AU - Ashina, M. AU - Kudrow, D. AU - Reuter, U. AU - Dolezil, D. AU - Silberstein, S. AU - Tepper, S. J. PY - 2019 DA - 2019// TI - Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: a pooled analysis of four placebo-controlled trials with long-term extensions JO - Cephalalgia. VL - 39 UR - https://doi.org/10.1177/0333102419888222 DO - 10.1177/0333102419888222 ID - Ashina2019 ER - TY - JOUR AU - Buse, D. C. AU - Fanning, K. M. AU - Reed, M. L. AU - Murray, S. AU - Dumas, P. K. AU - Adams, A. M. PY - 2019 DA - 2019// TI - Life with migraine: effects on relationships, career, and finances from the chronic migraine epidemiology and outcomes (CaMEO) study JO - Headache. VL - 59 UR - https://doi.org/10.1111/head.13613 DO - 10.1111/head.13613 ID - Buse2019 ER - TY - STD TI - GBD 2017 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858 ID - ref41 ER - TY - JOUR AU - Katsarava, Z. AU - Mania, M. AU - Lampl, C. AU - Herberhold, J. AU - Steiner, T. J. PY - 2018 DA - 2018// TI - Poor medical care for people with migraine in Europe - evidence from the Eurolight study JO - J Headache Pain. VL - 19 UR - https://doi.org/10.1186/s10194-018-0839-1 DO - 10.1186/s10194-018-0839-1 ID - Katsarava2018 ER - TY - JOUR AU - Ceriani, C. E. J. AU - Wilhour, D. A. AU - Silberstein, S. D. PY - 2019 DA - 2019// TI - Novel medications for the treatment of migraine JO - Headache. VL - 59 UR - https://doi.org/10.1111/head.13661 DO - 10.1111/head.13661 ID - Ceriani2019 ER - TY - JOUR AU - Scuteri, D. AU - Adornetto, A. AU - Rombola, L. AU - Naturale, M. D. AU - Morrone, L. A. AU - Bagetta, G. PY - 2019 DA - 2019// TI - New trends in migraine pharmacology: targeting calcitonin gene-related peptide (CGRP) with monoclonal antibodies JO - Front Pharmacol VL - 10 UR - https://doi.org/10.3389/fphar.2019.00363 DO - 10.3389/fphar.2019.00363 ID - Scuteri2019 ER - TY - JOUR AU - Ashina, M. AU - Goadsby, P. J. AU - Reuter, U. AU - Silberstein, S. AU - Dodick, D. AU - Rippon, G. A. PY - 2019 DA - 2019// TI - Long-term safety and tolerability of erenumab: three-plus year results from a five-year open-label extension study in episodic migraine JO - Cephalalgia. VL - 39 UR - https://doi.org/10.1177/0333102419854082 DO - 10.1177/0333102419854082 ID - Ashina2019 ER - TY - JOUR AU - Goadsby, P. J. AU - Paemeleire, K. AU - Broessner, G. AU - Brandes, J. AU - Klatt, J. AU - Zhang, F. PY - 2019 DA - 2019// TI - Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: a subgroup analysis of a randomized, double-blind, placebo-controlled study JO - Cephalalgia. VL - 39 UR - https://doi.org/10.1177/0333102419835459 DO - 10.1177/0333102419835459 ID - Goadsby2019 ER - TY - JOUR AU - Lipton, R. B. AU - Tepper, S. J. AU - Reuter, U. AU - Silberstein, S. AU - Stewart, W. F. AU - Nilsen, J. PY - 2019 DA - 2019// TI - Erenumab in chronic migraine: patient-reported outcomes in a randomized double-blind study JO - Neurology. VL - 92 UR - https://doi.org/10.1212/WNL.0000000000007452 DO - 10.1212/WNL.0000000000007452 ID - Lipton2019 ER - TY - JOUR AU - Reuter, U. AU - Goadsby, P. J. AU - Lanteri-Minet, M. AU - Wen, S. AU - Hours-Zesiger, P. AU - Ferrari, M. D. PY - 2018 DA - 2018// TI - Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study JO - Lancet. VL - 392 UR - https://doi.org/10.1016/S0140-6736(18)32534-0 DO - 10.1016/S0140-6736(18)32534-0 ID - Reuter2018 ER - TY - JOUR AU - Tepper, S. AU - Ashina, M. AU - Reuter, U. AU - Brandes, J. L. AU - Dolezil, D. AU - Silberstein, S. PY - 2017 DA - 2017// TI - Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial JO - Lancet Neurol VL - 16 UR - https://doi.org/10.1016/S1474-4422(17)30083-2 DO - 10.1016/S1474-4422(17)30083-2 ID - Tepper2017 ER - TY - JOUR AU - Dodick, D. W. AU - Ashina, M. AU - Brandes, J. L. AU - Kudrow, D. AU - Lanteri-Minet, M. AU - Osipova, V. PY - 2018 DA - 2018// TI - ARISE: a phase 3 randomized trial of erenumab for episodic migraine JO - Cephalalgia. VL - 38 UR - https://doi.org/10.1177/0333102418759786 DO - 10.1177/0333102418759786 ID - Dodick2018 ER - TY - JOUR AU - Goadsby, P. J. AU - Reuter, U. AU - Hallstrom, Y. AU - Broessner, G. AU - Bonner, J. H. AU - Zhang, F. PY - 2017 DA - 2017// TI - A controlled trial of erenumab for episodic migraine JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1705848 DO - 10.1056/NEJMoa1705848 ID - Goadsby2017 ER - TY - JOUR AU - Ashina, M. AU - Tepper, S. AU - Brandes, J. L. AU - Reuter, U. AU - Boudreau, G. AU - Dolezil, D. PY - 2018 DA - 2018// TI - Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: a subgroup analysis of a randomized, double-blind, placebo-controlled study JO - Cephalalgia. VL - 38 UR - https://doi.org/10.1177/0333102418788347 DO - 10.1177/0333102418788347 ID - Ashina2018 ER - TY - JOUR AU - Robbins, L. PY - 2020 DA - 2020// TI - Special report: CGRP monoclonal antibodies for chronic migraine JO - Practical Pain Management VL - 19 ID - Robbins2020 ER - TY - JOUR AU - Ornello, R. AU - Tiseo, C. AU - Frattale, I. AU - Perrotta, G. AU - Marini, C. AU - Pistoia, F. PY - 2019 DA - 2019// TI - The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal JO - J Headache Pain. VL - 20 UR - https://doi.org/10.1186/s10194-019-1054-4 DO - 10.1186/s10194-019-1054-4 ID - Ornello2019 ER - TY - JOUR AU - Buse, D. C. AU - Manack, A. AU - Serrano, D. AU - Turkel, C. AU - Lipton, R. B. PY - 2010 DA - 2010// TI - Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers JO - J Neurol Neurosurg Psychiatry VL - 81 UR - https://doi.org/10.1136/jnnp.2009.192492 DO - 10.1136/jnnp.2009.192492 ID - Buse2010 ER - TY - JOUR AU - Breslau, N. AU - Lipton, R. B. AU - Stewart, W. F. AU - Schultz, L. R. AU - Welch, K. M. PY - 2003 DA - 2003// TI - Comorbidity of migraine and depression: investigating potential etiology and prognosis JO - Neurology. VL - 60 UR - https://doi.org/10.1212/01.WNL.0000058907.41080.54 DO - 10.1212/01.WNL.0000058907.41080.54 ID - Breslau2003 ER - TY - JOUR AU - Yang, Y. AU - Zhao, H. AU - Heath, A. C. AU - Madden, P. A. AU - Martin, N. G. AU - Nyholt, D. R. PY - 2016 DA - 2016// TI - Shared genetic factors underlie migraine and depression JO - Twin Res Hum Genet VL - 19 UR - https://doi.org/10.1017/thg.2016.46 DO - 10.1017/thg.2016.46 ID - Yang2016 ER - TY - JOUR AU - Ashina, S. AU - Serrano, D. AU - Lipton, R. B. AU - Maizels, M. AU - Manack, A. N. AU - Turkel, C. C. PY - 2012 DA - 2012// TI - Depression and risk of transformation of episodic to chronic migraine JO - J Headache Pain VL - 13 UR - https://doi.org/10.1007/s10194-012-0479-9 DO - 10.1007/s10194-012-0479-9 ID - Ashina2012 ER - TY - JOUR AU - Sullivan, M. J. AU - Thorn, B. AU - Haythornthwaite, J. A. AU - Keefe, F. AU - Martin, M. AU - Bradley, L. A. PY - 2001 DA - 2001// TI - Theoretical perspectives on the relation between catastrophizing and pain JO - Clin J Pain VL - 17 UR - https://doi.org/10.1097/00002508-200103000-00008 DO - 10.1097/00002508-200103000-00008 ID - Sullivan2001 ER - TY - JOUR AU - Peters, M. L. AU - Vlaeyen, J. W. AU - Weber, W. E. PY - 2005 DA - 2005// TI - The joint contribution of physical pathology, pain-related fear and catastrophizing to chronic back pain disability JO - Pain. VL - 113 UR - https://doi.org/10.1016/j.pain.2004.09.033 DO - 10.1016/j.pain.2004.09.033 ID - Peters2005 ER - TY - JOUR AU - Severeijns, R. AU - Vlaeyen, J. W. AU - Hout, M. A. AU - Weber, W. E. PY - 2001 DA - 2001// TI - Pain catastrophizing predicts pain intensity, disability, and psychological distress independent of the level of physical impairment JO - Clin J Pain VL - 17 UR - https://doi.org/10.1097/00002508-200106000-00009 DO - 10.1097/00002508-200106000-00009 ID - Severeijns2001 ER - TY - JOUR AU - Holroyd, K. A. AU - Drew, J. B. AU - Cottrell, C. K. AU - Romanek, K. M. AU - Heh, V. PY - 2007 DA - 2007// TI - Impaired functioning and quality of life in severe migraine: the role of catastrophizing and associated symptoms JO - Cephalalgia. VL - 27 UR - https://doi.org/10.1111/j.1468-2982.2007.01420.x DO - 10.1111/j.1468-2982.2007.01420.x ID - Holroyd2007 ER - TY - JOUR AU - Vgontzas, A. AU - Pavlovic, J. M. PY - 2018 DA - 2018// TI - Sleep disorders and migraine: review of literature and potential pathophysiology mechanisms JO - Headache. VL - 58 UR - https://doi.org/10.1111/head.13358 DO - 10.1111/head.13358 ID - Vgontzas2018 ER - TY - JOUR AU - Kelman, L. AU - Rains, J. C. PY - 2005 DA - 2005// TI - Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs JO - Headache. VL - 45 UR - https://doi.org/10.1111/j.1526-4610.2005.05159.x DO - 10.1111/j.1526-4610.2005.05159.x ID - Kelman2005 ER - TY - JOUR AU - Sancisi, E. AU - Cevoli, S. AU - Vignatelli, L. AU - Nicodemo, M. AU - Pierangeli, G. AU - Zanigni, S. PY - 2010 DA - 2010// TI - Increased prevalence of sleep disorders in chronic headache: a case-control study JO - Headache. VL - 50 UR - https://doi.org/10.1111/j.1526-4610.2010.01711.x DO - 10.1111/j.1526-4610.2010.01711.x ID - Sancisi2010 ER - TY - JOUR AU - Klenofsky, B. AU - Pace, A. AU - Natbony, L. R. AU - Sheikh, H. U. PY - 2019 DA - 2019// TI - Episodic migraine comorbidities: avoiding pitfalls and taking therapeutic opportunities JO - Curr Pain Headache Rep VL - 23 UR - https://doi.org/10.1007/s11916-019-0742-8 DO - 10.1007/s11916-019-0742-8 ID - Klenofsky2019 ER - TY - JOUR AU - Yang, C. P. AU - Wang, S. J. PY - 2017 DA - 2017// TI - Sleep in patients with chronic migraine JO - Curr Pain Headache Rep VL - 21 UR - https://doi.org/10.1007/s11916-017-0641-9 DO - 10.1007/s11916-017-0641-9 ID - Yang2017 ER - TY - JOUR AU - Lipton, R. B. AU - Fanning, K. M. AU - Buse, D. C. AU - Martin, V. T. AU - Hohaia, L. B. AU - Adams, A. M. PY - 2019 DA - 2019// TI - Migraine progression in subgroups of migraine based on comorbidities: results of the CaMEO study JO - Neurology. VL - 93 UR - https://doi.org/10.1212/WNL.0000000000008589 DO - 10.1212/WNL.0000000000008589 ID - Lipton2019 ER - TY - JOUR AU - Louter, M. A. AU - Bosker, J. E. AU - Oosterhout, W. P. AU - Zwet, E. W. AU - Zitman, F. G. AU - Ferrari, M. D. PY - 2013 DA - 2013// TI - Cutaneous allodynia as a predictor of migraine chronification JO - Brain. VL - 136 UR - https://doi.org/10.1093/brain/awt251 DO - 10.1093/brain/awt251 ID - Louter2013 ER - TY - JOUR AU - Gil-Gouveia, R. AU - Oliveira, A. G. AU - Martins, I. P. PY - 2016 DA - 2016// TI - The impact of cognitive symptoms on migraine attack-related disability JO - Cephalalgia. VL - 36 UR - https://doi.org/10.1177/0333102415604471 DO - 10.1177/0333102415604471 ID - Gil-Gouveia2016 ER - TY - STD TI - Russo A, Silvestro M, Garramone F, Tessitore A, Cropano M, Scotto di Clemente F et al. A subjective cognitive impairments scale for migraine attacks: Validation of the Italian version of the MIG-SCOG. Neurol Sci. 2020 ID - ref71 ER - TY - JOUR AU - Vuralli, D. AU - Ayata, C. PY - 2018 DA - 2018// TI - Bolay H cognitive dysfunction and migraine JO - J Headache Pain. VL - 19 UR - https://doi.org/10.1186/s10194-018-0933-4 DO - 10.1186/s10194-018-0933-4 ID - Vuralli2018 ER - TY - JOUR AU - Bendtsen, L. AU - Sacco, S. AU - Ashina, M. AU - Mitsikostas, D. AU - Ahmed, F. AU - Pozo-Rosich, P. PY - 2018 DA - 2018// TI - Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European headache federation JO - J Headache Pain. VL - 19 UR - https://doi.org/10.1186/s10194-018-0921-8 DO - 10.1186/s10194-018-0921-8 ID - Bendtsen2018 ER - TY - JOUR AU - Tassorelli, C. AU - Aguggia, M. AU - Tommaso, M. AU - Geppetti, P. AU - Grazzi, L. AU - Pini, L. A. PY - 2017 DA - 2017// TI - Onabotulinumtoxin a for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers JO - J Headache Pain. VL - 18 UR - https://doi.org/10.1186/s10194-017-0773-7 DO - 10.1186/s10194-017-0773-7 ID - Tassorelli2017 ER - TY - JOUR AU - Kim, C. C. AU - Bogart, M. M. AU - Wee, S. A. AU - Burstein, R. AU - Arndt, K. A. AU - Dover, J. S. PY - 2010 DA - 2010// TI - Predicting migraine responsiveness to botulinum toxin type a injections JO - Arch Dermatol VL - 146 ID - Kim2010 ER - TY - JOUR AU - Sarchielli, P. AU - Granella, F. AU - Prudenzano, M. P. AU - Pini, L. A. AU - Guidetti, V. AU - Bono, G. PY - 2012 DA - 2012// TI - Italian guidelines for primary headaches: 2012 revised version JO - J Headache Pain. VL - 13 UR - https://doi.org/10.1007/s10194-012-0437-6 DO - 10.1007/s10194-012-0437-6 ID - Sarchielli2012 ER -